• Facebook
  • Instagram
  • Twitter
  • Home
  • Members
  • En Español
  • Contact
National Cancer Institute Clinical Oncology Research Program
SCOR - Southeast Clinical Oncology Research Consortium
  • Clinical Trials
  • Find a Doctor
  • About SCOR
    • Become a Member
  • Resources
    • Videos
    • Articles
    • Community Members
    • Community Support Groups
    • FAQs
    • Patient Resources
  • Menu Menu
  • Home
  • Members
  • En Español
  • Clinical Trials
  • Find a Clinical Trial Doctor
  • About SCOR
    • About SCOR
    • Become a Member of SCOR
  • Resources
    • Videos
    • News
    • Community Members
    • Community Support Groups
    • Clinical Trials FAQ
    • Clinical Trial Patient Resources
  • Contact SCOR
  • Privacy Policy
  • Site Map

Consent Forms

DARF

HIPAA Documents

Membership

Monthly Mail Memos

News and Upcoming Events

Patient Registration

Pharmacy

Protocol Index by Disease Category (PIDC)

Regulatory and IRB

CIRB Process (10)

Research Base Update List

SCOR Annual Conference

SCOR Chair-Based Home Exercise Pilot Project

SCOR Orientation & Training

Source Docs

Travel

  • Follow category
  • Unfollow category
Layout:
Showing 1-20 of 173
  • S2200 Cabozantinib 60mg DARF_ex25
  • S2200 Cabozantinib 20mg DARF_ex25
  • S2200 Atezolizumab DARF_ex25
  • NRG-HN010 Ado-Trastuzumab IV DARF_ex25
  • NRG-GY026 PHESGO 15 mL DARF_ex25
  • NRG-GY026 PHESGO 10 mL DARF_ex25
  • NRG-GY026 HYLECTA 600 mg DARF_ex25
  • A091903 Nivolumab 100mg DARF_ex25
  • S1900F Selpercatinib 80mg DARF_ex25
  • S1900F Selpercatinib 40mg DARF_ex25
  • EA9213 Dara SQ 1800mg DARF_ex25
  • A211801 Denosumab_placebo 120mg DARF_ex25
  • A221803-Mepitel Film DARF_ex25
  • S2107 Nivolumab 100mg/vial DARF_ex25
  • A031702 Cabozantinib 20 mg DARF_ex25
  • A221805 Duloxetine_placebo 30 mg A DARF_ex25
  • A091903 Cabozantinib_placebo 20 mg DARF_ex25
  • A091903 Cabozantinib 20 mg DARF_ex25
  • EA2187 Pevonedistat HCL 50mg DARF_ex25
  • EA2192 Olaparib_Placebo 100mg DARF_ex25
1 2 3 4 5 6 7 8 9 Next »

Consent Forms

DARF

HIPAA Documents

Membership

Monthly Mail Memos

News and Upcoming Events

Patient Registration

Pharmacy

Protocol Index by Disease Category (PIDC)

Regulatory and IRB

CIRB Process (10)

Research Base Update List

SCOR Annual Conference

SCOR Chair-Based Home Exercise Pilot Project

SCOR Orientation & Training

Source Docs

Travel

  • Follow category
  • Unfollow category
Layout:
Showing 1-20 of 173
  • S2200 Cabozantinib 60mg DARF_ex25
  • S2200 Cabozantinib 20mg DARF_ex25
  • S2200 Atezolizumab DARF_ex25
  • NRG-HN010 Ado-Trastuzumab IV DARF_ex25
  • NRG-GY026 PHESGO 15 mL DARF_ex25
  • NRG-GY026 PHESGO 10 mL DARF_ex25
  • NRG-GY026 HYLECTA 600 mg DARF_ex25
  • A091903 Nivolumab 100mg DARF_ex25
  • S1900F Selpercatinib 80mg DARF_ex25
  • S1900F Selpercatinib 40mg DARF_ex25
  • EA9213 Dara SQ 1800mg DARF_ex25
  • A211801 Denosumab_placebo 120mg DARF_ex25
  • A221803-Mepitel Film DARF_ex25
  • S2107 Nivolumab 100mg/vial DARF_ex25
  • A031702 Cabozantinib 20 mg DARF_ex25
  • A221805 Duloxetine_placebo 30 mg A DARF_ex25
  • A091903 Cabozantinib_placebo 20 mg DARF_ex25
  • A091903 Cabozantinib 20 mg DARF_ex25
  • EA2187 Pevonedistat HCL 50mg DARF_ex25
  • EA2192 Olaparib_Placebo 100mg DARF_ex25
1 2 3 4 5 6 7 8 9 Next »
National Cancer Institute Clinical Oncology Research Program, Grant #5UG1CA-189858. All content © Southeast Clinical Oncology Research Consortium. All rights reserved. 2150 Country Club Road, Suite 200, Winston-Salem, NC 27104-4241 | Phone: (336) 448-1417 | Fax: (336) 448-1425 | Site Map | Privacy Policy | Website Design by Built Creative.
  • Facebook
  • Instagram
  • Twitter
Scroll to top